Press Releases Bioxytran, Inc.

Equities

BIXT

US09075D1028

Market Closed - OTC Markets Other stock markets 15:44:45 2024-05-10 EDT			5-day change	1st Jan Change
0.1106 ^USD	+0.55%		+9.40%	-26.27%

04-19	Bioxytran, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-19	Bioxytran, Inc. Announces Board Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bioxytran : Change in Certifying Accountants - Form 8-K	05-09	PU
Bioxytran Announces Preprint of Shingles Case Study Showing Clearance Using a Topical Galectin-3 Antagonist	03-06	AQ
Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19	02-21	AQ
Bioxytran Gets Broad Patent Coverage on 60+ Viruses	23-10-24	AQ
Bioxytran Interview at the Emerging Growth Conference	23-10-04	AQ
Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M	23-09-14	AQ
Bioxytran Received IND Application by the FDA for Clinical Trials with ProLectin-M to Treat COVID-19 patients	23-09-07	AQ
Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials	23-08-31	AQ
Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials	23-08-24	AQ
Bioxytran Initiates a Registrational Trial of Oral ProLectin-M for Mild to Moderate COVID-19 Patients	23-08-08	AQ
Bioxytran Names Leslie Ajayi as Interim CMO and Head of the Medical Advisory Board	23-07-31	AQ
Bioxytran Peer-Reviewed Journal in “Vaccines” Contains Mechanism Capable of Targeting Future COVID-19 Mutations	23-06-27	AQ
Bioxytran Expands Institutional Investor Base with an additional $500,000 Equity Investment	23-06-12	AQ
Bioxytran Interview at the Emerging Growth Conference	23-05-01	AQ
Bioxytran Tests Acellular Oxygen Carrier BXT-25 in Pre-Clinical Trials	23-04-19	AQ
Bioxytran Interview at the Emerging Growth Conference	23-04-03	AQ
BIOXYTRAN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-31	AQ
Bioxytran Announces Positive Phase 2 Trial Results were Featured in “Vaccines” a Peer-Reviewed Journal	23-03-29	AQ
BIOXYTRAN, INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23-03-07	AQ
ProLectin-M Demonstrates Significant Activity Against Influenza and Respiratory Syncytial Virus	23-02-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bioxytran, Inc.

Equities

BIXT

US09075D1028

Press Releases

Filters